New Tools for Studying Receptor Dimers
New Tools for Studying Receptor Dimers
批准号:
10579320
负责人:
Paul J. Kammermeier
金额:
$19.25万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-03-01 至 2025-02-28
关键词:
AffinityAgonistAmino Acid SequenceBehaviorBiologicalBrainBrain regionCell membraneCicatrixClinicCloningColorCommunitiesComplexDataDimerizationDrug ScreeningEndoplasmic ReticulumEvaluationExcisionExhibitsExteinsFamilyFluorescence Resonance Energy TransferFutureG-Protein-Coupled ReceptorsGlutamatesHeterodimerizationHomoHomodimerizationKnowledgeLibrariesLigandsLinkMapsMembraneMembrane ProteinsMetabotropic Glutamate ReceptorsMethodsNeurotransmittersOrangesPathologyPerformancePharmacologyPhysiologyPopulationProteinsRNA SplicingReceptor SignalingResearchShapesSignal TransductionSirolimusSiteSynaptic TransmissionSystemTailTestingWorkdesigndimerdruggable targetglycoprotein 41inteinmetabotropic glutamate receptor 2metabotropic glutamate receptor 4notch proteinnovelpharmacologicpre-clinicalreceptorreceptor functionresponseretention ratesensortargeted treatmenttooltrafficking
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract
Metabotropic glutamate receptors (mGluRs) are class C G protein coupled receptors that function as dimers.
While mGluRs are known to form homodimers, more recent work has shown that they can also heterodimerize,
but not promiscuously. Because mGluRs exhibit widespread expression in the brain and regulate excitability and
plasticity, they have become candidates as druggable targets for a variety of pathologies. To date however,
excitement generated by preclinical data has not resulted in mGluR-targeting therapies in the clinic, despite a
wealth of available ligands with good selectivity targeting these receptors. Our recent work examining mGluR2/4
heterodimers provides a possible explanation: ligands that are highly efficacious when targeting homodimeric
receptors are often without effect when the same receptor is expressed as a heterodimer with another mGluR.
Further complicating matters, these changes in pharmacological responses observed in mGluR2/4 heterodimers
are not generalizable to all mGluR heterodimers, or even all mGluR2 containing heterodimers. Thus, to
understand how any mGluR ligand will function in the brain, we must examine the pharmacological responses
of each possible heterodimer pair in isolation. But this is complicated because every mGluR can also form
homodimers, so any pair of expressed mGluR will have an unknown propensity to homo- and heterodimerize.
To solve this problem, we have designed a novel dimer composition control system using a combination of ER
retention sequences paired with orthogonal, split inteins, self-excising protein sequences, that will allow
expression of pure populations of nearly wild type mGluR dimers of known composition. This system will be
valuable not only in defining the pharmacological behavior of each dimer pair, but also by providing a broader
and more accurate picture of the effects of mGluR targeting ligands by serving as a platform for broadly scoped
drug screening. Further, this strategy provides a template for the study of other dimerizing membrane proteins.
To this end, we will pursue the following Specific Aims: 1- Determine the performance and limitations of our
novel eukaryotic split-intein system, and 2- Generate and test each mGluR combination with the split-
intein system.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
A novel system for controlling dimeric receptor composition to discover unique heterodimer pharmacology
-
批准号:10735066
-
项目类别:
-
资助金额:$41.55万
-
财政年份:2023
-
负责人:Paul J. Kammermeier
-
依托单位:
New tools for studying receptor dimers
-
批准号:10430478
-
项目类别:
-
资助金额:$21.48万
-
财政年份:2022
-
负责人:Paul J. Kammermeier
-
依托单位:
Tools for studying the regulation of Homer protein splicing
-
批准号:10349911
-
项目类别:
-
资助金额:$15.4万
-
财政年份:2021
-
负责人:Paul J. Kammermeier
-
依托单位:
Functional and Pharmacological Implications of mGluR Heteromerization
-
批准号:8643265
-
项目类别:
-
资助金额:$29.42万
-
财政年份:2012
-
负责人:Paul J. Kammermeier
-
依托单位:
Functional and Pharmacological Implications of mGluR Heteromerization
-
批准号:8452668
-
项目类别:
-
资助金额:$28.42万
-
财政年份:2012
-
负责人:Paul J. Kammermeier
-
依托单位:
Functional and Pharmacological Implications of mGluR Heteromerization
-
批准号:9036403
-
项目类别:
-
资助金额:$33.18万
-
财政年份:2012
-
负责人:Paul J. Kammermeier
-
依托单位:
Functional and Pharmacological Implications of mGluR Heteromerization
-
批准号:8829302
-
项目类别:
-
资助金额:$35.86万
-
财政年份:2012
-
负责人:Paul J. Kammermeier
-
依托单位:
Functional and Pharmacological Implications of mGluR Heteromerization
-
批准号:8270968
-
项目类别:
-
资助金额:$30.74万
-
财政年份:2012
-
负责人:Paul J. Kammermeier
-
依托单位:
Functional and Pharmacological Implications of mGluR Heteromerization
-
批准号:8726532
-
项目类别:
-
资助金额:$1.04万
-
财政年份:2012
-
负责人:Paul J. Kammermeier
-
依托单位:
G PROTEIN COUPLING OF GROUP I MGLURS
-
批准号:6330388
-
项目类别:
-
资助金额:$4.2万
-
财政年份:2000
-
负责人:Paul J. Kammermeier
-
依托单位:
G PROTEIN COUPLING OF GROUP I MGLURS
-
批准号:6054754
-
项目类别:
-
资助金额:$3.67万
-
财政年份:1999
-
负责人:Paul J. Kammermeier
-
依托单位:
国内基金
海外基金
Agonist-GPR119-Gs复合物的结构生物学研究
-
批准号:32000851
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:乔安娜
-
依托单位: